New treatment improves outcomes for children with rare cancer
A new treatment combining anti-tumour drugs with chemotherapy shows promise in improving the chances of patients with neuroblastoma, a rare form of children's cancer.
The clinical trial found that patients who received the drug had better one-year progression-free survival rates compared to the control group.